Per earlier note we are long on $NUVA from $40.30. Take partial profits right here at $42.30 and tighten the stop band. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized
The FDA Peripheral and Central Nervous System Drugs Advisory Committee meets today to review ACOR’s Fampridine-SR for improvement of walking in patients with multiple sclerosis . We have been negative on ACOR from the very beginning of Fampridine saga because even if the drug works as ACOR promotes, it is
As per our earlier post, we are short on INTC from $21.85. Take partial profits right here at $21.36 and take more profits if the stock goes lower. Tighten the stop. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY
$CSX is a major rail carrier for coal to utilities. The commentary with earnings is negative for coal stocks. Consider opportunistically short selling with tight stops $CNX, $BTU, $ACI, and $MEE. Our other screens are bearish on coal stocks. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE
In response to questions, if INTC spikes up , we will consider short selling as the stock approaches $22 and stop over $23. Of course these are the levels for a perfect trade, which is not likely. We will consider shorting at lower levels depending on details of the earnings,
NUVA stock has been down today on rumors that JNJ (Johnson & Johnson) will announce a lateral fusion device in the post earnings conference call. JNJ web site shows that the head of its device business will be on the call indicating there may be some truth to the rumor.
INTEL reports earnings next week. Commentary from the Wall Street is almost universally positive. In the middle of this bullishness, our screens, especially fund flows, show that the smart money is selling into strength. If the earnings are good, the probability is that the good earnings are the result of
Consider start scaling in a short position in MDT right here at $36.20. MDT had passed all of our screens for a short sale, but we had been waiting for a trigger that the market pays attention to before entering the trade. Patience in entering short sales is especially important